There are over 32 million adults in the US living with diabetes....

There are over 32 million adults in the US living with diabetes. At US $390.75 per test, the total addressable market size in the US comes to US $12.5 billion. PIQ has given guidance on licensing fees of approximately 10%, equating to a potential US $1.25 billion market for them in licensing fees. That’s about AU $1.9 billion.

Based on PIQ’s current market cap of ~$124 million, the total addressable market in the US alone is 15X the market cap in rough annual revenue. This also assumes just one test per patient per year. Where as the test is recommended to be administered 1-4 times per year based on the degree of risk.

So, capturing just 10% of the market would still yield a gross profit of 1.5X their current market cap. There’s no competing test. So why not a 42% share? That’s the total amount covered by the Medicare and Medicaid rebate. That would be a gross profit 6X their current market cap.



while Im ramping this, actually just quoting someone elses ramp, I notice the retest of my 100 fib today. Market willing 1.43 test this week now it closed over the 127 fib. And look at the 'dog gone' weekly volume and its only Tuesday. Next 10 weeks promise to be massive.